Christopher I Wright
CIK 1838503 · Lihat di SEC EDGAR ↗
Pengajuan SEC Pertama: 17 April 2026 · Terbaru: 12 Juni 2026
Di halaman ini
- Orang Dalam di Perusahaan di mana orang ini adalah orang dalam yang melaporkan.
- Transaksi orang dalam Setiap saham yang dibeli atau dijual orang ini, dari pengajuan Formulir 4.
- Derivatif Opsi dan kepemilikan derivatif lainnya yang dilaporkan oleh orang ini.
- Kepemilikan Awal Kepemilikan yang dimiliki orang ini saat pertama kali mulai melaporkan.
- Kompensasi Gaji eksekutif yang diungkapkan dalam pernyataan proksi perusahaan.
Orang Dalam di
Transaksi orang dalam
Perubahan harga vs kuotasi saat ini, disesuaikan split untuk aksi korporasi sejak pengajuan — tidak dibenchmark, tidak diannualisasi, tidak dibobot berdasarkan ukuran
| Tanggal | Ticker | Kode | Saham | Harga | Nilai | Dimiliki setelah | Δ milik | A/D | vs sekarang |
|---|---|---|---|---|---|---|---|---|---|
| 12 Juni 2026 | ALKS | S 10b5-1 | 2.000 | $45,10 | $90.200 | 25.680 Langsung | -7,23% | Dilepas | 12,4% (harga per 2026-08-19) |
| 25 Feb. 2021 | CYCN | S 10b5-1 | 2.637 | $3,99 | $10.522 | 42.728 Langsung | -5,81% | Dilepas | -94,8% (harga per 2026-08-19) |
P = Pembelian pasar terbuka · S = Penjualan · A = Hibah/penghargaan · B = Pelaksanaan opsi · G = Hadiah · F = Pemotongan pajak
Transaksi orang dalam bukan merupakan rekomendasi; penjualan sering kali didorong oleh alasan likuiditas atau pajak.
Kepemilikan Derivatif (Formulir 4 Tabel II)
Opsi, RSU, dan sekuritas konversi yang dilaporkan pada Formulir 4 Tabel II.
| Tanggal | Ticker | Sekuritas | Underlying | Harga Pelaksanaan | Kedaluwarsa | Saham | A/D |
|---|---|---|---|---|---|---|---|
| 8 Juni 2025 | ALKS | Restricted Stock Unit Award | Ordinary Shares (3.301) | — | — | 3.301 | Dilepas |
| 31 Mei 2025 | ALKS | Restricted Stock Unit Award | Ordinary Shares (8.013) | — | — | 8.013 | Dilepas |
| 21 Mei 2025 | ALKS | Restricted Stock Unit Award | Ordinary Shares (6.142) | — | — | 6.142 | Diakuisisi |
| 21 Mei 2025 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (13.474) | $30,53 | 21 Mei 2035 | 13.474 | Diakuisisi |
| 29 Juni 2024 | ALKS | Restricted Stock Unit Award | Ordinary Shares (6.104) | — | — | 6.104 | Dilepas |
| 8 Juni 2024 | ALKS | Restricted Stock Unit Award | Ordinary Shares (3.301) | — | — | 3.301 | Dilepas |
| 31 Mei 2024 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (17.492) | $23,40 | 31 Mei 2034 | 17.492 | Diakuisisi |
| 31 Mei 2024 | ALKS | Restricted Stock Unit Award | Ordinary Shares (8.013) | — | — | 8.013 | Diakuisisi |
| 17 Nov. 2023 | ALKS | Restricted Stock Unit Award [F1] | Ordinary Shares (119) | — | — | 119 | Diakuisisi |
| 17 Nov. 2023 | ALKS | Non Qualified Stock Option (Right to Buy) [F1] | Ordinary Shares (254) | $30,72 | 29 Juni 2033 | 254 | Diakuisisi |
| 17 Nov. 2023 | ALKS | Non Qualified Stock Option (Right to Buy) [F1] | Ordinary Shares (231) | $30,86 | 7 Juli 2032 | 231 | Diakuisisi |
| 17 Nov. 2023 | ALKS | Restricted Stock Unit Award [F1] | Ordinary Shares (129) | — | — | 129 | Diakuisisi |
| 17 Nov. 2023 | ALKS | Non Qualified Stock Option (Right to Buy) [F1] | Ordinary Shares (355) | $28,40 | 8 Juni 2032 | 355 | Diakuisisi |
| 17 Nov. 2023 | ALKS | Non Qualified Stock Option (Right to Buy) [F1] | Ordinary Shares (14) | $28,40 | 8 Juni 2032 | 14 | Diakuisisi |
| 7 Juli 2023 | ALKS | Restricted Stock Unit Award | Ordinary Shares (5.957) | — | — | 5.957 | Dilepas |
| 29 Juni 2023 | ALKS | Restricted Stock Unit Award | Ordinary Shares (5.985) | — | — | 5.985 | Diakuisisi |
| 29 Juni 2023 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (12.732) | $31,33 | 29 Juni 2033 | 12.732 | Diakuisisi |
| 8 Juni 2023 | ALKS | Restricted Stock Unit Award | Ordinary Shares (3.236) | — | — | 3.236 | Dilepas |
| 8 Juni 2023 | ALKS | Restricted Stock Unit Award | Ordinary Shares (373) | — | — | 373 | Dilepas |
| 7 Juli 2022 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (11.554) | $31,48 | 7 Juli 2032 | 11.554 | Diakuisisi |
| 7 Juli 2022 | ALKS | Restricted Stock Unit Award | Ordinary Shares (5.957) | — | — | 5.957 | Diakuisisi |
| 8 Juni 2022 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (17.773) | $28,97 | 8 Juni 2032 | 17.773 | Diakuisisi |
| 8 Juni 2022 | ALKS | Restricted Stock Unit Award | Ordinary Shares (9.709) | — | — | 9.709 | Diakuisisi |
| 8 Juni 2022 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (714) | $28,97 | 8 Juni 2032 | 714 | Diakuisisi |
| 8 Juni 2022 | ALKS | Restricted Stock Unit Award | Ordinary Shares (373) | — | — | 373 | Diakuisisi |
Harga pelaksanaan/konversi kosong jika tidak berlaku (misalnya, RSU).
Kepemilikan Awal (Formulir 3) 16 saham
Sekuritas yang dipegang saat pertama kali menjadi orang dalam, sesuai Formulir 3 SEC.
| Tanggal | Ticker | Sekuritas | Saham | Kepemilikan |
|---|---|---|---|---|
| 17 April 2026 | WVE | Ordinary Shares | 45.625 | Langsung |
| 17 April 2026 | WVE | Share Option (Right to Buy)→ Ordinary Shares (300.000) | 300.000 | Langsung |
| 17 April 2026 | WVE | Share Option (Right to Buy)→ Ordinary Shares (273.750) | 273.750 | Langsung |
| 30 Des. 2020 | CYCN | Common Stock | 17.009 | Langsung |
| 30 Des. 2020 | CYCN | Common Stock | 28.356 | Langsung |
| 30 Des. 2020 | CYCN | Employee Stock Option (Right to Buy)→ Common Stock | — | Langsung |
| 30 Des. 2020 | CYCN | Employee Stock Option (Right to Buy)→ Common Stock | — | Langsung |
| 30 Des. 2020 | CYCN | Employee Stock Option (Right to Buy)→ Common Stock | — | Langsung |
| 30 Des. 2020 | CYCN | Employee Stock Option (Right to Buy)→ Common Stock | — | Langsung |
| 30 Des. 2020 | CYCN | Employee Stock Option (Right to Buy)→ Common Stock | — | Langsung |
| 30 Des. 2020 | CYCN | Employee Stock Option (Right to Buy)→ Common Stock | — | Langsung |
| 30 Des. 2020 | CYCN | Employee Stock Option (Right to Buy)→ Common Stock (23.437) | 23.437 | Langsung |
| 30 Des. 2020 | CYCN | Employee Stock Option (Right to Buy)→ Common Stock (51.563) | 51.563 | Langsung |
| 30 Des. 2020 | CYCN | Employee Stock Option (Right to Buy)→ Common Stock (75.000) | 75.000 | Langsung |
| 30 Des. 2020 | CYCN | Employee Stock Option (Right to Buy)→ Common Stock (1.562) | 1.562 | Langsung |
| 30 Des. 2020 | CYCN | Employee Stock Option (Right to Buy)→ Common Stock (73.438) | 73.438 | Langsung |
Kompensasi (DEF 14A)
Dicocokkan berdasarkan nama dari pernyataan proksi (DEF 14A) — verifikasi terhadap pengajuan.
CYCN
M.D., Ph.D,(4)Chief Medical Officer| Tahun fiskal | Gaji | Bonus | Penghargaan saham | Penghargaan opsi | Insentif non-ekuitas | Perubahan Pensiun | Lainnya | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $456.125 | — | — | $144.495 | $158.328 | — | $8.132 | $767.080 |
Angka-angka dari Tabel Kompensasi Ringkasan dalam pernyataan proksi perusahaan (DEF 14A). Kompensasi bukan merupakan rekomendasi.